Some limitations on emergency contraception are eased

Article

The FDA approved a new one-pill formulation of the emergency contraceptive Plan B in July.

The Food and Drug Administration (FDA) approved a new one-pill formulation of the emergency contraceptive (EC) Plan B in July. Called Plan B One-Step, the product is available behind the counter without a prescription to women 17 or older. The FDA also recently approved Next Choice, a generic version of the original two-pill Plan B formulation, which is obtainable by prescription to those 17 or younger.

The American College of Obstetricians and Gynecologists (ACOG) praised the recent FDA actions, saying the new formulation "will simplify this important pregnancy prevention treatment" (ACOG press release, 7/15/09). However, ACOG also reiterated its "long-held position that there is no valid scientific or medical reason to impose an age restriction on the availability of EC because it is safe and effective for adolescents and women of all ages." It urged the FDA "to withdraw the age restriction altogether and eliminate the behind-the-counter status for EC."

Related Videos
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Related Content
© 2024 MJH Life Sciences

All rights reserved.